Pfizer
Utility Patents
Last updated:
List of all Pfizer patents 177 in total
| Status | Patent |
|---|---|
Grant | Utility: Crystalline form of lorlatinib free base Filling date: 13 Sep 2025 Issue date: 1 Jun 2021 |
Grant | Utility: Soluble fibroblast growth factor receptor 3 (SFGFR3) polypeptides and uses thereof Filling date: 13 Sep 2025 Issue date: 1 Jun 2021 |
Grant | Utility: Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof Filling date: 13 Sep 2025 Issue date: 1 Jun 2021 |
Grant | Utility: Heteroaromatic compounds and their use as dopamine D1 ligands Filling date: 13 Sep 2025 Issue date: 25 May 2021 |
Grant | Utility: CDK2 inhibitors Filling date: 13 Sep 2025 Issue date: 25 May 2021 |
Grant | Utility: Chemical compounds Filling date: 13 Sep 2025 Issue date: 25 May 2021 |
Grant | Utility: Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors Filling date: 13 Sep 2025 Issue date: 27 Apr 2021 |
Grant | Utility: Aminopyrimidinyl compounds Filling date: 13 Sep 2025 Issue date: 20 Apr 2021 |
Grant | Utility: Compositions and methods relating to a mutant Clostridium difficile toxin Filling date: 13 Sep 2025 Issue date: 20 Apr 2021 |
Grant | Utility: N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors Filling date: 13 Sep 2025 Issue date: 13 Apr 2021 |
Grant | Utility: Cyclopentane-based modulators of STING (stimulator of interferon genes) Filling date: 13 Sep 2025 Issue date: 6 Apr 2021 |
Grant | Utility: Stability-modulating linkers for use with antibody drug conjugates Filling date: 13 Sep 2025 Issue date: 6 Apr 2021 |
Grant | Utility: Pyrrolo[2,3-d]pyrimidine derivatives Filling date: 13 Sep 2025 Issue date: 6 Apr 2021 |
Grant | Utility: BTLA fusion protein agonists and uses thereof Filling date: 13 Sep 2025 Issue date: 30 Mar 2021 |
Grant | Utility: Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same Filling date: 13 Sep 2025 Issue date: 23 Mar 2021 |
Grant | Utility: PDE4 inhibitor (R)-4-(5-(4-methoxy-3-propoxyphenyl)pyridin-3-yl)-1,2-oxaborolan-2-ol Filling date: 13 Sep 2025 Issue date: 16 Mar 2021 |
Grant | Utility: Group B Streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof Filling date: 13 Sep 2025 Issue date: 16 Mar 2021 |
Grant | Utility: Media and fermentation methods for producing polysaccharides in bacterial cell culture Filling date: 13 Sep 2025 Issue date: 16 Mar 2021 |
Grant | Utility: Combinations comprising a pyrrolidine-2,5-dione IDO1 inhibitor and an anti-body Filling date: 13 Sep 2025 Issue date: 16 Mar 2021 |
Grant | Utility: Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2- -methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof Filling date: 13 Sep 2025 Issue date: 9 Mar 2021 |
Grant | Utility: Engineered polypeptide conjugates and methods for making thereof using transglutaminase Filling date: 13 Sep 2025 Issue date: 9 Mar 2021 |
Grant | Utility: GLP-1 receptor agonists and uses thereof Filling date: 13 Sep 2025 Issue date: 2 Mar 2021 |
Grant | Utility: Anti-CXCR4 antibodies and antibody-drug conjugates Filling date: 13 Sep 2025 Issue date: 23 Feb 2021 |
Grant | Utility: Streptococcus pneumoniae capsular polysaccharides and conjugates thereof Filling date: 13 Sep 2025 Issue date: 16 Feb 2021 |
Grant | Utility: Recombinant ROBO2 proteins, compositions, methods and uses thereof Filling date: 13 Sep 2025 Issue date: 2 Feb 2021 |
Grant | Utility: Pyrimidine carboxamides as inhibitors of Vanin-1 enzyme Filling date: 13 Sep 2025 Issue date: 2 Feb 2021 |
Grant | Utility: Neisseria meningitidis compositions and methods thereof Filling date: 13 Sep 2025 Issue date: 26 Jan 2021 |
Grant | Utility: Combination of a PD-1 antagonist and a 4-1BB agonist for treating cancer Filling date: 13 Sep 2025 Issue date: 26 Jan 2021 |
Grant | Utility: Stable aqueous anti-vascular endothelial growth factor (VEGF) antibody formulation Filling date: 13 Sep 2025 Issue date: 19 Jan 2021 |
Grant | Utility: Neisseria meningitidis compositions and methods thereof Filling date: 13 Sep 2025 Issue date: 12 Jan 2021 |
Grant | Utility: Tissue factor pathway inhibitor antibodies and uses thereof Filling date: 13 Sep 2025 Issue date: 29 Dec 2020 |
Grant | Utility: Anti-CXCR5 antibodies and compositions and uses thereof Filling date: 13 Sep 2025 Issue date: 29 Dec 2020 |
Grant | Utility: PD-L1 antagonist combination treatments Filling date: 13 Sep 2025 Issue date: 22 Dec 2020 |
Grant | Utility: Bifunctional cytotoxic agents containing the CTI pharmacophore Filling date: 13 Sep 2025 Issue date: 22 Dec 2020 |
Grant | Utility: Heterocyclic spiro compounds as MAGL inhibitors Filling date: 13 Sep 2025 Issue date: 8 Dec 2020 |
Grant | Utility: GLP-1 receptor agonists and uses thereof Filling date: 13 Sep 2025 Issue date: 1 Dec 2020 |
Grant | Utility: Anti-proliferative agents for treating PAH Filling date: 13 Sep 2025 Issue date: 1 Dec 2020 |
Grant | Utility: Tissue-specific genome engineering using CRISPR-Cas9 Filling date: 13 Sep 2025 Issue date: 1 Dec 2020 |
Grant | Utility: Dosage regimen for MAdCAM antagonists Filling date: 13 Sep 2025 Issue date: 1 Dec 2020 |
Grant | Utility: Reagents for fluorosulfating alcohols or amines Filling date: 13 Sep 2025 Issue date: 17 Nov 2020 |
Grant | Utility: Neisseria meningitidis composition and methods thereof Filling date: 13 Sep 2025 Issue date: 10 Nov 2020 |
Grant | Utility: Interferon beta antibodies and uses thereof Filling date: 13 Sep 2025 Issue date: 10 Nov 2020 |
Grant | Utility: N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors Filling date: 13 Sep 2025 Issue date: 3 Nov 2020 |
Grant | Utility: RSV F protein mutants Filling date: 13 Sep 2025 Issue date: 3 Nov 2020 |
Grant | Utility: Pyrazolo[1,5-a]pyrazin-4-yl derivatives Filling date: 13 Sep 2025 Issue date: 3 Nov 2020 |
Grant | Utility: Neisseria meningitidis compositions and methods thereof Filling date: 13 Sep 2025 Issue date: 27 Oct 2020 |
Grant | Utility: Manufacturing process and intermediates for a pyrrolo[2,3-d]pyrimidine compound and use thereof Filling date: 13 Sep 2025 Issue date: 27 Oct 2020 |
Grant | Utility: Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR Filling date: 13 Sep 2025 Issue date: 27 Oct 2020 |
Grant | Utility: Bruton's tyrosine kinase inhibitors Filling date: 13 Sep 2025 Issue date: 27 Oct 2020 |
Grant | Utility: CDK2/4/6 inhibitors Filling date: 13 Sep 2025 Issue date: 13 Oct 2020 |
Showing 50 to 100 of 177 patents.